Associated Papers
EEF2-Related Neurodevelopmental Disorder Is Clinically Recognizable.
Prasun P et al.
Molecular Syndromology, 2024
Neoantigen landscape supports feasibility of personalized cancer vaccine for follicular lymphoma.
Ramirez CA et al.
Blood Advances, 2024
38713894 (PubMed )
Supplement: BLOODA_ADV-2022-007792-mmc6.xlsx › Supp_Table6
Expansion of clinical and variant spectrum of EEF2-related neurodevelopmental disorder: Report of two additional cases.
Guo R et al.
American Journal of Medical Genetics. Part A, 2023
A novel de novo variant in CASK causes a severe neurodevelopmental disorder that masks the phenotype of a novel de novo variant in EEF2.
Rodríguez-García ME et al.
Journal of Human Genetics, 2023
De Novo variants in EEF2 cause a neurodevelopmental disorder with benign external hydrocephalus.
Nabais Sá MJ et al.
Human Molecular Genetics, 2021
Select a paper to view details